Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping

2006 ◽  
Vol 13 (1-2) ◽  
pp. 50-52 ◽  
Author(s):  
Y.M.D. Lo
Transfusion ◽  
2022 ◽  
Author(s):  
Agnieszka Orzińska ◽  
Anna Kluska ◽  
Aneta Balabas ◽  
Magdalena Piatkowska ◽  
Maria Kulecka ◽  
...  

Transfusion ◽  
2019 ◽  
Vol 59 (3) ◽  
pp. 1102-1107 ◽  
Author(s):  
Agnieszka Orzińska ◽  
Katarzyna Guz ◽  
Michal Mikula ◽  
Anna Kluska ◽  
Aneta Balabas ◽  
...  

2011 ◽  
Vol 18 (6) ◽  
pp. 467-473 ◽  
Author(s):  
Peter G. Scheffer ◽  
Masja de Haas ◽  
C. Ellen van der Schoot

Molecules ◽  
2021 ◽  
Vol 26 (3) ◽  
pp. 556
Author(s):  
Bonwoo Koo ◽  
Haneul Yoo ◽  
Ho Jeong Choi ◽  
Min Kim ◽  
Cheoljae Kim ◽  
...  

The expanding scope of chemical reactions applied to nucleic acids has diversified the design of nucleic acid-based technologies that are essential to medicinal chemistry and chemical biology. Among chemical reactions, visible light photochemical reaction is considered a promising tool that can be used for the manipulations of nucleic acids owing to its advantages, such as mild reaction conditions and ease of the reaction process. Of late, inspired by the development of visible light-absorbing molecules and photocatalysts, visible light-driven photochemical reactions have been used to conduct various molecular manipulations, such as the cleavage or ligation of nucleic acids and other molecules as well as the synthesis of functional molecules. In this review, we describe the recent developments (from 2010) in visible light photochemical reactions involving nucleic acids and their applications in the design of nucleic acid-based technologies including DNA photocleaving, DNA photoligation, nucleic acid sensors, the release of functional molecules, and DNA-encoded libraries.


2004 ◽  
Vol 50 (4) ◽  
pp. 689-693 ◽  
Author(s):  
Tuangsit Wataganara ◽  
Erik S LeShane ◽  
Angela Y Chen ◽  
Lynn Borgatta ◽  
Inga Peter ◽  
...  

Abstract Background: Reports of placental mRNA sequences in the plasma of pregnant women suggest that the placenta is the predominant source of cell-free fetal nucleic acids in maternal plasma during pregnancy. We developed an assay for γ-globin mRNA concentrations to determine whether hematopoietic cells also contribute to the pool of fetal mRNA in maternal plasma. Methods: Frozen paired plasma samples obtained from 40 women before and within 20 min after elective first-trimester termination of pregnancy (TOP) were analyzed. Fresh plasma samples from eight nonpregnant individuals were included as controls. Plasma γ-globin mRNA was measured by use of real-time reverse transcription-PCR and analyzed with gestational age. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was used to confirm the presence of cell-free RNA in each sample. Results: γ-Globin and GAPDH mRNA sequences were detected in every plasma sample. The concentrations of both messages were significantly increased in pregnancy (P <0.01). The concentrations of γ-globin mRNA were decreased in most women after TOP, but γ-globin mRNA was increased in some patients when TOP was performed later than 9 weeks of gestation. Conclusions: γ-Globin mRNA sequences can be detected and measured in fresh and frozen plasma samples. Plasma γ-globin and GAPDH mRNA concentrations are affected by pregnancy. The increased posttermination γ-globin mRNA concentrations seen in some patients suggest that the source of this message is fetal hematopoietic cells. Further study in pregnant women after 9 weeks of gestation is necessary to evaluate the potential of γ-globin mRNA as a marker for fetomaternal hemorrhage.


2012 ◽  
Vol 19 (6) ◽  
pp. 462-468 ◽  
Author(s):  
Nancy Bo Yin Tsui ◽  
Yuk Ming Dennis Lo

Sign in / Sign up

Export Citation Format

Share Document